StockNews.AI
SOPH
StockNews.AI
119 days

SOPHiA GENETICS to Announce Financial Results for First Quarter 2025 on May 6, 2025

1. SOPHiA GENETICS will release Q1 2025 financial results on May 6, 2025. 2. A conference call will discuss results and business outlook at 8:00 a.m. EDT. 3. SOPHiA GENETICS specializes in data-driven medicine utilizing AI technology.

Earnings
+9.53%Current Return
VS
+4.4%S&P 500
$2.7804/22 08:07 AM EDTEvent Start
$3.04504/23 02:43 PM EDTLatest Updated
4m saved
Insight
Article

FAQ

Why Bullish?

Upcoming financial results could showcase growth and future potential, similar to past successful earnings calls that drove stock price increases.

How important is it?

Earnings reports significantly influence investor sentiment, particularly for growth companies like SOPH.

Why Short Term?

Immediate market reactions to upcoming earnings, similar to historical trends seen in Q1 announcements.

Related Companies

NVTAILMNRGEN
, /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today announced it will release its financial results for the first quarter 2025 before U.S. markets open on Tuesday, May 6, 2025. On that day, SOPHiA GENETICS will host a conference call to discuss its financial results as well as business outlook beginning at 8:00 a.m. (08:00) EDT / 2:00 p.m. (14:00) CET. The call will be webcast live on the SOPHiA GENETICS Investor Relations Website. Additionally, a replay will be available on the website after its completion. About SOPHiA GENETICS SOPHiA GENETICS (Nasdaq: SOPH) is a software company on a mission to expand access to data-driven medicine by using AI to deliver world-class care to patients with cancer and rare disorders across the globe. It is the creator of the SOPHiA DDM™ Platform, a cloud-native platform that analyzes complex multimodal data – including genomics, radiomics, clinical, biological, and digital pathology data – to generate real-time, actionable insights for a broad global network of hospital, laboratory, and biopharma institutions. For more information, visit SOPHiAGENETICS.COM and connect with us on LinkedIn. SOURCE SOPHiA GENETICS WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM? 440k+ Newsrooms & Influencers 9k+ Digital Media Outlets 270k+ Journalists Opted In

Related News